Rebecca Karp Leaf

2.2k total citations
53 papers, 395 citations indexed

About

Rebecca Karp Leaf is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Rebecca Karp Leaf has authored 53 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Hematology and 12 papers in Genetics. Recurrent topics in Rebecca Karp Leaf's work include Porphyrin Metabolism and Disorders (12 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Rebecca Karp Leaf is often cited by papers focused on Porphyrin Metabolism and Disorders (12 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Rebecca Karp Leaf collaborates with scholars based in United States, Israel and Canada. Rebecca Karp Leaf's co-authors include Amy K. Dickey, David E. Leaf, Hanny Al‐Samkari, Katayoon Goodarzi, Kerry L. Reynolds, David Avigan, Sara Schoenfeld, Jean M. Connors, Michael Dougan and Galina Gheihman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Rebecca Karp Leaf

46 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Karp Leaf United States 11 131 111 110 82 59 53 395
Bendik Lund Norway 14 139 1.1× 137 1.2× 92 0.8× 45 0.5× 99 1.7× 29 660
Katarzyna Derwich Poland 12 131 1.0× 110 1.0× 86 0.8× 45 0.5× 34 0.6× 70 550
Frank Alvaro Australia 15 183 1.4× 173 1.6× 102 0.9× 102 1.2× 182 3.1× 45 752
Jutte van der Werff ten Bosch Belgium 15 123 0.9× 113 1.0× 210 1.9× 61 0.7× 193 3.3× 57 671
Ebba K. Lindqvist Sweden 11 199 1.5× 101 0.9× 119 1.1× 74 0.9× 17 0.3× 21 393
Stephen Fung Germany 10 120 0.9× 84 0.8× 192 1.7× 27 0.3× 30 0.5× 39 415
José Carlos Morais Brazil 13 52 0.4× 224 2.0× 59 0.5× 87 1.1× 120 2.0× 37 468
Patrick Elder United States 17 380 2.9× 237 2.1× 126 1.1× 109 1.3× 166 2.8× 71 768
L. Appaji India 10 68 0.5× 79 0.7× 58 0.5× 25 0.3× 25 0.4× 45 288
D Pei United States 7 215 1.6× 113 1.0× 123 1.1× 73 0.9× 31 0.5× 7 729

Countries citing papers authored by Rebecca Karp Leaf

Since Specialization
Citations

This map shows the geographic impact of Rebecca Karp Leaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Karp Leaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Karp Leaf more than expected).

Fields of papers citing papers by Rebecca Karp Leaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Karp Leaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Karp Leaf. The network helps show where Rebecca Karp Leaf may publish in the future.

Co-authorship network of co-authors of Rebecca Karp Leaf

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Karp Leaf. A scholar is included among the top collaborators of Rebecca Karp Leaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Karp Leaf. Rebecca Karp Leaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ducamp, Sarah, Min Wu, Juan Putra, et al.. (2025). The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria. Journal of Clinical Investigation. 135(18). 1 indexed citations
2.
Leaf, Rebecca Karp, Hetanshi Naik, Sarina B. Elmariah, et al.. (2024). Afamelanotide for Treatment of the Protoporphyrias: Impact on Quality of Life and Laboratory Parameters in a US Cohort. Life. 14(6). 689–689. 2 indexed citations
3.
Dickey, Amy K. & Rebecca Karp Leaf. (2024). Givosiran: a targeted treatment for acute intermittent porphyria. Hematology. 2024(1). 426–433. 5 indexed citations
4.
Leaf, Rebecca Karp, et al.. (2024). New definitions for antiphospholipid syndrome: ready for clinical use?. Hematology. 2024(1). 222–226. 1 indexed citations
5.
Leaf, Rebecca Karp & Amy K. Dickey. (2024). Porphyria cutanea tarda: a unique iron-related disorder. Hematology. 2024(1). 450–456.
6.
Leiva, Orly, Andrew Jenkins, Rachel Rosovsky, et al.. (2023). Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms. SHILAP Revista de lepidopterología. 15(2). 398–404. 5 indexed citations
7.
Leaf, Rebecca Karp, David J. Kuter, Katayoon Goodarzi, et al.. (2023). Avatrombopag for adults with early versus chronic immune thrombocytopenia. American Journal of Hematology. 99(2). 155–162. 6 indexed citations
8.
Leaf, Rebecca Karp, David J. Kuter, Katayoon Goodarzi, et al.. (2023). Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia. Blood. 142(Supplement 1). 392–392. 1 indexed citations
9.
Leaf, Rebecca Karp, et al.. (2023). Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements. JAMA Dermatology. 159(2). 204–204. 6 indexed citations
10.
Leiva, Orly, Andrew Jenkins, Rachel Rosovsky, et al.. (2022). Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation. Journal of Cardiology. 81(3). 260–267. 11 indexed citations
11.
Dickey, Amy K., Rebecca Karp Leaf, Sarina B. Elmariah, et al.. (2022). Prospective observational pilot study of quantitative light dosimetry in erythropoietic protoporphyria. Journal of the American Academy of Dermatology. 88(5). 1148–1151. 6 indexed citations
12.
Leiva, Orly, Siyang Ren, Donna Neuberg, et al.. (2022). Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease. International Journal of Hematology. 117(1). 90–99. 11 indexed citations
13.
Leaf, Rebecca Karp, et al.. (2022). Clinical Experience with Afamelanotide for the Protoporphyrias in the United States. Blood. 140(Supplement 1). 2201–2202. 1 indexed citations
14.
Goodarzi, Katayoon, et al.. (2021). Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy‐induced thrombocytopenia. American Journal of Hematology. 96(12). 1563–1568. 10 indexed citations
15.
Leaf, Rebecca Karp, Deepa Rangachari, James W. Mier, et al.. (2019). Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors. American Journal of Hematology. 94(5). 563–574. 49 indexed citations
16.
Schoenfeld, Sara, Mary E. Aronow, Rebecca Karp Leaf, Michael Dougan, & Kerry L. Reynolds. (2019). Diagnosis and Management of Rare Immune-Related Adverse Events. The Oncologist. 25(1). 6–14. 24 indexed citations
17.
Leaf, Rebecca Karp, et al.. (2019). A case of severe hypothyroidism due to lenalidomide. SHILAP Revista de lepidopterología. 7(9). 1747–1749. 1 indexed citations
18.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2017). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Molecular Cancer Therapeutics. 16(10). 2304–2314. 10 indexed citations
19.
Bar‐Natan, Michal, Dina Stroopinsky, Katarina Luptakova, et al.. (2017). Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. British Journal of Haematology. 176(6). 929–938. 23 indexed citations
20.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2016). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Blood. 128(22). 4175–4175. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bendik Lund Breakdown of academic impact, for papers by Katarzyna Derwich Breakdown of academic impact, for papers by Frank Alvaro Breakdown of academic impact, for papers by Jutte van der Werff ten Bosch Breakdown of academic impact, for papers by Ebba K. Lindqvist Breakdown of academic impact, for papers by Stephen Fung Breakdown of academic impact, for papers by José Carlos Morais Breakdown of academic impact, for papers by Patrick Elder Breakdown of academic impact, for papers by L. Appaji Breakdown of academic impact, for papers by D Pei
Rankless by CCL
2026